Clinical characteristics at baseline and at the end of the study. by Naruyoshi Gyoutoku (22537831)

Myocardial <i>Shroom3</i> loss during development does not alter ventricular wall thickness. by Jennifer L. Carleton (22208916)

Mean scores, standard deviations, and significance on key measures and subscales by gender group. by Silas Manning (22693338)

Subjects:

Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation. by Narendran Gopalan (110148)

Respiratory clinical characteristics of smokers and non-smokers. by Prasanna Herath (20714794)

Subjects:

Baseline clinical and treatment features of patients with LLA ASCC. by Aihong Zheng (20571034)

FBP primarily decreases the protein level of HMGB1 by promoting its lysosomal degradation upon viral infection. by Penghui Hu (695020)

EF-24 induces significant transcriptional changes in K-562 cells. by Ajeet P. Singh (22298432)

Subjects:

Identification of ACADM, ANGPTL4, and NFKB2 as significant predictors of OS in the TCGA-KIRC cohort. by Yu Zhang (12946)

Subjects:

Voxel-based whole-hemisphere analysis shows regional and dose-dependent decrease of microglia. by Francesca Catto (21253435)

The growth of co-transformed cells in the peritoneal cavity alters their cellular gene expression to mirror that of PEL biopsies. by Mitchell Hayes (5334887)

Data Sheet 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Data Sheet 3_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.docx by David Qixiang Chen (8198265)

“…We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Proposed model of how morphological plasticity contributes to echinocandin tolerance acquisition in <i>C. tropicalis</i> clinical isolates. by Yongqin Wu (272012)

“…Throughout this process, intricate alterations occur in the expression of genes (e.g., <i>CHS2</i> and <i>GSC1</i>) associated with the cell wall in both tolerant and non-tolerant strains, with a significant downregulation of genes (e.g., <i>ACE2</i>) related to cell division in the tolerant strains. …”

A prepubertal CD decreases plasma leptin and cholesterol concentrations in adulthood despite a chronic HFD in Sprague-Dawley male rats. by Ana Aguilar-Lozano (20614619)

The spike-in of synthetic hsa-lest-7a-5p miRNA decreases the Ct Values of extracted small RNA samples. by Marc Van Der Hofstadt (1423027)

Patients’ demographics and clinical parameters. by Zi-Rong Chen (9227618)

a-d. Difference in (a) probing depth; (b) clinical attachment level; (c) bleeding on probing, and (d) plaque index values between baseline and six months after treatment using syst... by Iva Milinkovic (22331710)

Subjects:

Means, standard deviations, and inferential statistics for the outcomes in the three conditions tested. by Robert Trybulski (10998702)

Subjects: